• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFB050523
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation of Vessels (2135)
Event Date 07/26/2023
Event Type  Death  
Event Description
It was reported that patient death occurred.A left atrial appendage closure procedure was being performed.A versacross connected was utilized with a watchman for transseptal puncture (tsp).The versacross connect and was were positioned into the right atrium.When advancing the versacross connect for tsp, the versacross rf wire perforated the aorta, causing fatal bleeding.Thus, a surgical intervention was attempted for aortic perforation repair, but it was unsuccessful, and the patient died on the table.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that patient death occurred.A left atrial appendage closure procedure was being performed.A versacross connected was utilized with a watchman for transseptal puncture (tsp).The versacross connect and was were positioned into the right atrium.When advancing the versacross connect for tsp, the versacross rf wire perforated the aorta, causing fatal bleeding.Thus, a surgical intervention was attempted for aortic perforation repair, but it was unsuccessful, and the patient died on the table.It was further reported (29aug2023) that no pericardial effusion nor cardiac tamponade were noted.The tenting on the versacross wire was visible prior to the rf application (1-4 mm).There were no multiple attempts required to track up / drop down into position on septum before tsp was performed, and only one rf was applied.The versacross devices were not pushed very quickly, but they went straight into aorta.Both versacross rf wire and dilator crossed the septum.The patient had a very narrow lipominous septum.No issues with versacross devices were reported.
 
Manufacturer Narrative
Due to additional information received on 29aug2023, the field b5 (describe event or problem) was updated.And, to correction, the field b7 (other relevant history) was updated, thus the supplemental report will be filed.It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17566963
MDR Text Key321371192
Report Number2124215-2023-43688
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public00685447012573
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFB050523
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/26/2023
Initial Date FDA Received08/17/2023
Supplement Dates Manufacturer Received08/29/2023
Supplement Dates FDA Received09/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/08/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age76 YR
Patient SexFemale
Patient RaceWhite
-
-